Caris Life Sciences (NASDAQ:CAI) executives said the company is expanding its commercial reach, product pipeline and ...

Contract Research Organization for the Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Informed the Company ...

Achieve Life Sciences (ACHV) downgraded to Hold as FDA CRL risk delays cytisinicline NDA to Q4 2026. Read the latest analysis ...

Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused ...

（2027年4月28日，中国上海）4月27日，复星医药（600196.SH；02196.HK）与总部位于阿联酋阿布扎比的全球性生命科学公司Arcera Life Sciences LLC OPC（以下简称“Arcera”）签署合作备忘录，双方将聚焦全球生命科学领域的授权许可、技术开发、神经科学领域创新及价值创造，建立长期战略合作关系。 复星医药联席总裁、创新药事业部首席执行官王兴利与Arcera首 ...

China behind only US and UK in ranking, reflecting the country’s ‘major scale’ in AI, biotechnology and talent, says Deep ...

Life sciences is too important to let promising innovation stall because the business side was underbuilt. Fractional ...

Grant program expands access to advanced single-domain antibody technologies to support the research and development of next-generation therapies ...

Achieve Life Sciences (ACHV) is scheduled to announce Q1 earnings results on Tuesday, May 12th, before market open. The consensus EPS Estimate is -$0.30 (+18.9% Y/Y) and the consensus Revenue Estimate ...